42omics
Unlocking Leapfrogs in Biotech
We make biological simulation radically more efficient, unlocking whole-system simulations at atomic resolution. By simulating biology at unprecedented scale and fidelity, we enable de novo insights and a new approach to preclinical testing. This enables the discovery of entirely new therapies, as well as increasing their chances of making it through clinical trials.
The Problem
Biotech is blocked
Biology tells us what may be possible, but biotech still struggles to make it work in patients.
Rudimentary understanding
Our understanding of biology remains limited. For example, the function of roughly 38% of human genes is still unknown.
Discoveries rarely reach patients
Promising biological discoveries rarely translate into effective therapies. Over 90% of drug candidates fail in clinical trials.
Untapped potential
Biotech still captures only a fraction of what science makes possible. Epigenetic reprogramming, for instance, opens the door to cellular rejuvenation that remains largely unexplored.
The solution
Simulation changes the game
Physics-based, whole-system simulation solves many of biotech's hardest problems: It generates de novo insight, captures the hidden drivers of clinical failure, and enables systematic, large-scale exploration of causal relationships. All while being faster, cheaper, and more scalable than traditional lab experiments.
The challenge: unlocking the full potential of simulation requires holistic, atomic-resolution models that go beyond isolated phenomena. Even whole-cell simulations of the simplest known organisms remain impractically slow on today’s high-performance computers. We change that.
Our approach
Faster simulations. Better outcomes.
We make simulation radically more efficient, unlocking whole-system simulation for biotech. This closes the gap between what simulation makes possible and what today’s hardware can run, step by step, from optimized algorithms to purpose-built hardware.
- Algorithmic & execution optimization
- Spatial & temporal approximation
- Specialized hardware
Get in Touch
Unlock what's possible
If you work in pharma, biopharma, or as a CRO and want to explore how fast, whole-system simulation can transform drug discovery and development, we’d love to hear from you.